Pilot Study of Revian Red All LED Cap Device for Treating Central Centrifugal Cicatricial Alopecia in Adult Women

What this Trial Is About

Central centrifugal cicatricial alopecia CCCA is a type of scarring hair loss mainly affecting middle-aged women of African descent. This condition causes patches of scarred scalp that grow larger over time, leading to brittle, shorter hair and symptoms like itching, pain, and tenderness. Since CCCA can cause permanent hair loss and distress, effective treatments are needed, but current options are limited and not well studied. This study evaluates the Revian Red All LED cap, a wireless device that uses two wavelengths of light 620 nm and 660 nm once daily for 10 minutes, to see if it can reduce inflammation, stop hair loss, and encourage regrowth in people with CCCA. Five women diagnosed with CCCA will use the cap daily for six months. Photos and dermatoscope images will be taken every two months to track changes in hairline and hair growth. Participants will complete questionnaires about their hair loss symptoms at each visit. The study measures include hairline stabilization and regrowth at multiple time points over six months. The research team aims to assess if this light therapy can help manage CCCA symptoms and hair loss. The entire study lasts six months, with ongoing monitoring and symptom evaluation during that time.

A Pilot Study of Revian Red All LED Cap as a Novel Treatment for Central Centrifugal Cicatricial Alopecia